Jabra Enhance Select 500 vs Otofonix Encore

The Jabra Enhance Select 500 is a premium behind-the-ear OTC hearing aid priced at $1,995 that earns an A grade with a SoundScore of 4.2/5 in our lab testing. This places it in the top 18% of the OTC hearing aid category, ranking #13 among 65 tested devices. In our testing, speech clarity in quiet environments stands out as a key strength, scoring 4.3/5—a strong result that measures 1.50 points above the category average. Feedback handling is excellent at 4.6/5, ensuring stable performance during everyday movements. Music streaming quality scores 2.9/5, which is 0.98 points above the category average but only mixed in absolute terms. The device shows some limitations worth noting. Speech understanding in noisy environments scores 1.8/5, which is above the category average by 0.31 points but low in absolute terms—a common challenge across OTC devices. Own-voice comfort scores 2.2/5, falling 0.31 points below the category average, which may be noticeable for users sensitive to how their own voice sounds. This two-time Expert's Choice Award winner (2023, 2024) offers rechargeable batteries and streaming compatibility with both iPhone and Android devices, including hands-free calling. Consumers seeking similar sound quality at a lower price point may want to compare the Jabra Enhance Select 300 or Lucid Engage. The Enhance Select 500 is best suited for those prioritizing strong speech clarity in quieter settings and reliable streaming performance within the premium OTC segment.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.